72067419CA00004
Cooperative Agreement
Overview
Grant Description
Evidence is a program of applied research and evaluation, including cost and cost effectiveness analysis, cost modeling, and epidemiological analysis, aimed at assisting the Government of South Africa to achieve the goals of its National Strategic Plan on HIV, TB and STIs 2017-2022, national and international 90-90-90 targets, and PEPFAR objectives.
Awardee
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
South Africa
Geographic Scope
Foreign
Related Opportunity
None
Analysis Notes
Amendment Since initial award the End Date has been extended from 11/30/23 to 11/30/24 and the total obligations have increased 358% from $3,000,000 to $13,726,705.
Wits Health Consortium (Pty) was awarded
Research & Evaluation for SA Govt's HIV/TB/STI Plan
Cooperative Agreement 72067419CA00004
worth $13,726,705
from U.S. Mission to South Africa in December 2018 with work to be completed primarily in South Africa.
The grant
has a duration of 6 years and
was awarded through assistance program 98.001 USAID Foreign Assistance for Programs Overseas.
Status
(Complete)
Last Modified 10/31/23
Period of Performance
12/1/18
Start Date
11/30/24
End Date
Funding Split
$13.7M
Federal Obligation
$0.0
Non-Federal Obligation
$13.7M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for 72067419CA00004
Transaction History
Modifications to 72067419CA00004
Additional Detail
Award ID FAIN
72067419CA00004
SAI Number
72067419CA00004-P012
Award ID URI
SAI NOT AVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
720674 USAID/SOUTH AFRICA
Funding Office
720674 USAID/SOUTH AFRICA
Awardee UEI
KNNNGEN9MQB8
Awardee CAGE
SBN74
Performance District
Not Applicable
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Global Health Programs, State (019-1031) | International development and humanitarian assistance | Grants, subsidies, and contributions (41.0) | $15,576,705 | 100% |
Modified: 10/31/23